OpenURL Connection Search

Select item for more details and to access through your institution.

Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
Published in:
European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
By:
- Vaduganathan, Muthiah;
- Claggett, Brian L.;
- Lam, Carolyn S.P.;
- Pitt, Bertram;
- Senni, Michele;
- Shah, Sanjiv J.;
- Voors, Adriaan A.;
- Zannad, Faiez;
- Desai, Akshay S.;
- Jhund, Pardeep S.;
- Viswanathan, Prabhakar;
- Bomfim Wirtz, Antonieta;
- Schloemer, Patrick;
- Lay‐Flurrie, James;
- McMurray, John J.V.;
- Solomon, Scott D.
Publication type:
Article
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.
Published in:
2018
By:
- Voors, Adriaan A.;
- Shah, Sanjiv J.;
- Bax, Jeroen J.;
- Butler, Javed;
- Gheorghiade, Mihai;
- Hernandez, Adrian F.;
- Kitzman, Dalane W.;
- McMurray, John J.V.;
- Wirtz, Antonieta Bomfim;
- Lanius, Vivian;
- van der Laan, Michael;
- Solomon, Scott D.
Publication type:
journal article
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Published in:
2019
By:
- Shah, Sanjiv J.;
- Voors, Adriaan A.;
- McMurray, John J. V.;
- Kitzman, Dalane W.;
- Viethen, Thomas;
- Bomfim Wirtz, Antonieta;
- Huang, Erya;
- Pap, Akos Ferenc;
- Solomon, Scott D.
Publication type:
journal article

Found: 3

Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.

Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.

Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.